Partillion Bioscience Corporation announced the closing of a $5 million seed financing round, expansion of its board of directors, and a multiyear agreement with Alloy Therapeutics, Inc. as a Preferred Partner providing antibody discovery services using Partillion’s Nanovial technology.
September 26, 2023
· 4 min read
